MAP1B

Chr 5AD

microtubule associated protein 1B

Also known as: DFNA83, FUTSCH, MAP5, PPP1R102, PVNH9

This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The product of this gene is a precursor polypeptide that presumably undergoes proteolytic processing to generate the final MAP1B heavy chain and LC1 light chain. Gene knockout studies of the mouse microtubule-associated protein 1B gene suggested an important role in development and function of the nervous system. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.132 OMIM phenotypes
Clinical SummaryMAP1B
🧬
Gene-Disease Validity (ClinGen)
periventricular nodular heterotopia · ADStrong

Strong evidence — appropriate for clinical testing

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
40 unique Pathogenic / Likely Pathogenic· 418 VUS of 648 total submissions
📖
GeneReview available — MAP1B
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.13LOEUF
pLI 1.000
Z-score 7.72
OE 0.06 (0.030.13)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
2.51Z-score
OE missense 0.80 (0.760.85)
1051 obs / 1306.4 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.06 (0.030.13)
00.351.4
Missense OE?0.80 (0.760.85)
00.61.4
Synonymous OE?1.00
01.21.6
LoF obs/exp: 5 / 79.1Missense obs/exp: 1051 / 1306.4Syn Z: -0.05

This gene — mechanism propensity

DN
0.2598th %ile
GOF
0.3392th %ile
LOF
0.80top 5%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 95% of P/LP variants are LoF · LOEUF 0.13
DN1 literature citation

Literature Evidence

DNBecause the gene targeting event in these mice produced a gene encoding a 571-amino acid truncated product of MAP1B, it seems likely that the phenotypes seen arise from the truncated MAP1B product acting in a dominant-negative fashion, rather than a loss of MAP1B function.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 9199175

ClinVar Variant Classifications

648 submitted variants in ClinVar

Classification Summary

Pathogenic19
Likely Pathogenic21
VUS418
Likely Benign152
Benign21
Conflicting4
19
Pathogenic
21
Likely Pathogenic
418
VUS
152
Likely Benign
21
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
18
1
0
0
19
Likely Pathogenic
20
1
0
0
21
VUS
4
412
2
0
418
Likely Benign
0
69
3
80
152
Benign
0
9
0
12
21
Conflicting
4
Total42492592635

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

6 pathogenic / likely-pathogenic (of 11) ClinVar copy-number / structural variants overlap MAP1B — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MAP1B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →